Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 592

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 592
---
 the license.

Summary of development milestones:

| Milestone                                           |     | Amount |         |
|:----------------------------------------------------|:----|:-------|--------:|
| Commercial approval by US FDA or foreign equivalent |     | $      | 100,000 |
| First commercial sale                               |     |        | 100,000 |
| Aggregate net sales of $3.0 million                 |     |        | 100,000 |
| Aggregate net sales of $10.0 million                |     |        | 100,000 |
| Aggregate net sales of $25.0 million                |     |        | 100,000 |

| F-73 |

aegeria soft tissue llc

notes to the financial statements (UNAUDITED)

The following tables summarizes the Company’s related party balances with JHU as of September 30, 2024 and December 31, 2023:

| Nature of Transaction                       |     | Balance Sheet Classification      |     | 2024 | September 30, |     | 2023 | December 31, |
|:--------------------------------------------|:----|:----------------------------------|:----|:-----|--------------:|:----|:-----|-------------:|
| Patent maintenance reimbursement obligation |     | Accounts payable-related party    |     | $    |        61,801 |     | $    |       51,891 |
| Patent maintenance reimbursement obligation |     | Accrued liabilities-related party |     | $    |           750 |     | $    |        6,147 |

Note 5 – Loss per Common Unit

The following table presents the computation of basic and diluted net loss per unit attributable to common unitholder’s:

| Numerator:                                             |     | Three Months Ended September 30, 
 2024                             |           |   |     | 2023 |           |   |     | Nine Months Ended September 30, 
 2024                            |           |   |     | 2023 |           |   |
|:-------------------------------------------------------|:----|:---------------------------------|----------:|:--|:----|:-----|----------:|:--|:----|:--------------------------------|----------:|:--|:----|:-----|----------:|:--|
| Net loss                                               |     | $                                |    (9,161 | ) |     | $    |    (5,988 | ) |     | $                               |   (25,630 |